News and Events

The Institute for Advanced Clinical Trials for Children (I-ACT for Children) is pleased to welcome Laura Gordon as Chief Executive Officer. Ms. Gordon is a highly experienced executive leader with expertise in health policy and communications, organizational development and stakeholder engagement in the public and private healthcare sectors. She most recently was General Manager of…

Recruiting a sufficient number of participants to complete a pediatric trial is often a major limitation within an efficacious study. To combat this issue, the Institute for Advanced Clinical Trials for Children (I-ACT for Children) is constructing a network of hospital centers and university sites that have demonstrated the appropriate resources to carry out pediatric…

The Institute for Advanced Clinical Trials for Children (I-ACT for Children) is excited to announce that Dr. Collin Hovinga has joined the organization as the Senior Vice President, Clinical and Scientific Development. Dr. Hovinga is recognized as a thought leader in pediatric pharmacology and has held appointments with the FDA’s Peripheral and Central Nervous System…

Over the past three months, I-ACT for Children has welcomed three new members to its team. These new members will support the growth of our network sites and management ongoing projects: Laura Lopez will be supporting and developing internal processes as the Assistant Director, Executive Administration and Office Management. Stephen McConoughey will be working in project…

The Institute for Advanced Clinical Trials for Children (I-ACT for Children) is pleased to announce that Elizabeth Garofalo, MD has joined the Institute as a Member of its Board of Directors. Dr. Garofalo was previously the Senior Vice President at Novartis Pharmaceuticals Corporation with a > 25-year career in drug development.  She has participated in…

Rockville, MD The US Food and Drug Administration has awarded the Institute for Advanced Clinical Trials for Children (I-ACT for Children) a grant to improve clinical trials of new drugs and devices for children. The award establishes an alliance among I-ACT for Children and PEDSnet, the James M. Anderson Center for Health Systems Excellence, Critical…

Rockville, MD. The Institute for Advanced Clinical Trials for Children (I-ACT for Children) announced that James J. Pomfret ChFC®, CLU®, AIF®, Managing Director – Investment Officer at Wells Fargo Advisors, has joined the Institute as a member of its Board of Directors. Mr. Pomfret was previously a Budget Analyst with the Social Security Administration, after…

The Institute for Advanced Clinical Trials for Children (aka, I-ACT for Children) is pleased to announce the appointment of Lisa Benson to the position of Vice President, Clinical Research Operations, Quality and Education, beginning June 5. Lisa is a highly-respected research administrator and clinical operations expert.  She comes to I-ACT for Children from the Department…

This week, Critical Path Institute’s Pediatric Trials Consortium (PTC) reported the completion of its objectives in record time (PTC Deliverables). These includes the posting of the Executive Summary of PTC’s Advisory Report and support for the launch of the Institute for Advanced Clinical Trials for Children, aka I-ACT for Children. The PTC Advisory Report represents the…